These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 29122133)

  • 21. Late clinical outcomes of lambre versus amplatzer occluders for left atrial appendage closure.
    Schnupp S; Liu XX; Buffle E; Gloekler S; Mohrez Y; Cheikh-Ibrahim M; Allakkis W; Brachmann J; Park JW; Kleinecke C
    J Cardiovasc Electrophysiol; 2020 Apr; 31(4):934-942. PubMed ID: 32072692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early Canadian Multicenter Experience With WATCHMAN for Percutaneous Left Atrial Appendage Closure.
    Saw J; Fahmy P; Azzalini L; Marquis JF; Hibbert B; Morillo C; Carrizo A; Ibrahim R
    J Cardiovasc Electrophysiol; 2017 Apr; 28(4):396-401. PubMed ID: 28128883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in Left Atrial Appendage Dimensions Following Volume Loading During Percutaneous Left Atrial Appendage Closure.
    Spencer RJ; DeJong P; Fahmy P; Lempereur M; Tsang MYC; Gin KG; Lee PK; Nair P; Tsang TSM; Jue J; Saw J
    JACC Cardiovasc Interv; 2015 Dec; 8(15):1935-1941. PubMed ID: 26738661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac CT and echocardiographic evaluation of peri-device flow after percutaneous left atrial appendage closure using the AMPLATZER cardiac plug device.
    Jaguszewski M; Manes C; Puippe G; Salzberg S; Müller M; Falk V; Lüscher T; Luft A; Alkadhi H; Landmesser U
    Catheter Cardiovasc Interv; 2015 Feb; 85(2):306-12. PubMed ID: 25205611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of Early (1-Week) Outcomes Following Left Atrial Appendage Closure With Amplatzer Devices.
    Koskinas KC; Shakir S; Fankhauser M; Nietlispach F; Attinger-Toller A; Moschovitis A; Wenaweser P; Pilgrim T; Stortecky S; Praz F; Räber L; Windecker S; Meier B; Gloekler S
    JACC Cardiovasc Interv; 2016 Jul; 9(13):1374-83. PubMed ID: 27388826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin: A Pooled, Patient-Level Analysis of the WATCHMAN Randomized Trial Experience.
    Price MJ; Reddy VY; Valderrábano M; Halperin JL; Gibson DN; Gordon N; Huber KC; Holmes DR
    JACC Cardiovasc Interv; 2015 Dec; 8(15):1925-1932. PubMed ID: 26627989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new left atrial appendage occluder (Lifetech LAmbre Device) for stroke prevention in atrial fibrillation.
    Lam YY
    Cardiovasc Revasc Med; 2013; 14(3):134-6. PubMed ID: 23773494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double device left atrial appendage closure.
    Guérios ÊE; Gloekler S; Schmid M; Khattab A; Nietlispach F; Meier B
    EuroIntervention; 2015 Aug; 11(4):470-6. PubMed ID: 25007782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Left Atrial Appendage Closure With the New Occlutech® Device: First in Man Experience and Neurological Outcome.
    Bellmann B; Schnupp S; Kühnlein P; Javernik C; Kleinecke C; Rillig A; Landmesser U; Brachmann J; Park JW
    J Cardiovasc Electrophysiol; 2017 Mar; 28(3):315-320. PubMed ID: 27925332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Impact of Left Atrial Appendage Patency After Device Closure.
    Chen M; Yao PC; Fei ZT; Wang QS; Yu YC; Zhang PP; Li W; Zhang R; Mo BF; Zhao MZ; Yu Y; Yang M; Zhao Y; Gong CQ; Sun J; Li YG
    Circ Cardiovasc Interv; 2024 May; 17(5):e013579. PubMed ID: 38629273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left atrial appendage orifice diameter measured with trans-esophageal echocardiography is independently related with peri-device leakage after Watchman device implantation.
    Chen YY; Zhang YH; Chen X; Huang WP; Xu B; Su X; Chen YH
    Int J Cardiovasc Imaging; 2019 Oct; 35(10):1831-1839. PubMed ID: 31321654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An overview of current and emerging devices for percutaneous left atrial appendage closure.
    Chow DHF; Wong YH; Park JW; Lam YY; De Potter T; Rodés-Cabau J; Asmarats L; Sandri M; Sideris E; McCaw T; Lee RJ; Sievert H; Søndergaard L; De Backer O
    Trends Cardiovasc Med; 2019 May; 29(4):228-236. PubMed ID: 30205924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-term safety and efficacy of left atrial appendage closure with the WATCHMAN device in patients with small left atrial appendage ostia.
    Venkataraman G; Strickberger SA; Doshi S; Ellis CR; Lakkireddy D; Whalen SP; Cuoco F
    J Cardiovasc Electrophysiol; 2018 Jan; 29(1):17-21. PubMed ID: 28877379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Periprocedural intracardiac echocardiography for left atrial appendage closure: a dual-center experience.
    Berti S; Paradossi U; Meucci F; Trianni G; Tzikas A; Rezzaghi M; Stolkova M; Palmieri C; Mori F; Santoro G
    JACC Cardiovasc Interv; 2014 Sep; 7(9):1036-44. PubMed ID: 25234677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcatheter closure of the left atrial appendage: A focused update on the Watchman closure device.
    Khalili H; Mansi IA; Hanzel GS; Banerjee S
    Catheter Cardiovasc Interv; 2018 Jul; 92(1):E28-E34. PubMed ID: 28471004
    [No Abstract]   [Full Text] [Related]  

  • 36. Percutaneous left atrial appendage occlusion: Effect of device positioning on outcome.
    Wolfrum M; Attinger-Toller A; Shakir S; Gloekler S; Seifert B; Moschovitis A; Khattab A; Maisano F; Meier B; Nietlispach F
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):656-664. PubMed ID: 27465268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and Safety of the WATCHMAN Left Atrial Appendage System for Stroke Prevention in Chinese Patients with Nonvalvular Atrial Fibrillation: A Single-center, Prospective, Observational Study.
    Huang WP; Zhang YH; He L; Su X; Yang XW; Guo ZX
    Chin Med J (Engl); 2017 Feb; 130(4):434-438. PubMed ID: 28218217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amplatzer left atrial appendage occlusion: single center 10-year experience.
    Nietlispach F; Gloekler S; Krause R; Shakir S; Schmid M; Khattab AA; Wenaweser P; Windecker S; Meier B
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):283-9. PubMed ID: 23412815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thromboembolic events and need for anticoagulation therapy following left atrial appendage occlusion in patients with electrical isolation of the appendage.
    Gadiyaram VK; Mohanty S; Gianni C; Trivedi C; Al-Ahmad A; Burkhardt DJ; Gallinghouse JG; Hranitzky PM; Horton RP; Sanchez JE; Della Rocca DG; Di Biase L; Price MJ; Couts L; Gibson D; Natale A
    J Cardiovasc Electrophysiol; 2019 Apr; 30(4):511-516. PubMed ID: 30623500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.